Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $2.6M | $4.5M | $0 | $4.0M |
| Cost of revenue | $0 | $847.0K | $949.8K | $0 | $3.9K | $846.8K |
| Gross profit | $0 | −$847.0K | $1.7M | $4.5M | −$3.9K | $3.1M |
| Gross margin | — | — | 63.7% | 100.0% | — | 78.7% |
| R&D | $0 | $3.8M | $6.1M | $14.4M | $11.1M | $9.8M |
| Operating income | −$64.0K | −$15.1M | −$15.1M | −$25.1M | −$20.7M | −$15.1M |
| EBITDA | −$64.0K | −$14.3M | −$13.6M | −$24.0M | −$11.2M | −$9.1M |
| Net income | −$64.0K | −$15.1M | −$15.9M | −$25.5M | −$12.5M | −$10.4M |
| Net margin | — | — | -607.5% | -566.0% | — | -262.8% |
| EPS (diluted) | -0.02 | -4.64 | -4.42 | -5.89 | -1.80 | -0.77 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $380M | $0.00 | $0.00–$0.00 | 0 |
| 2027 | $481M | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
CHIMERIC THERAPEAUTCS
No one on the platform currently holds CHMMF.
No tracked institution reports a position in CHMMF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2026-04-22 | 1-for-100reverse |
No one on the platform has traded CHMMF yet.
| $13M |
| — |
| NSHSFNanoSphere Health Sciences Inc. | $0.01 | +0.00% | $98642 | — |
| PHRRFPharmaTher Holdings Ltd. | $0.04 | +1.56% | $4M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.